Ivermectin News and Research

RSS

Ivermectin (22,23-dihydroavermectin B1a + 22,23-dihydroavermectin B1b) is a broad-spectrum antiparasitic medication. It is traditionally used against worms, but more recently found to be effective against mites and some lice too. Ivermectin is currently being used to help eliminate river blindness (onchocerciasis) in the Americas and stop transmission of lymphatic filariasis around the world.

BBC examines river blindness program in sub-Saharan Africa

BBC examines a campaign in sub-Saharan Africa that is helping to distribute drugs to prevent onchocerciasis, also known as river blindness - a disease "caused by a parasite that is spread from human to human by the black fly, which once flourished along river beds where there is fast-flowing water."

21 Jun 2009

DNA "barcodes" used to map mosquito species in West Africa that spread lymphatic filariasis

New biotechnologies that allow scientists to quickly and accurately distinguish species based on a simple DNA analysis are being creatively deployed for the first time in the war against a major global disease.

29 Apr 2009

River blindness under control in Escuintla, Guatemala

An international team of researchers led by Rodrigo Gonzalez of the Universidad del Valle de Guatemala reports that the transmission of onchocerciasis or river blindness has been broken in Escuintla, Guatemala, one of the largest endemic areas in the Western Hemisphere to date to stop the transmission of the parasitic disease.

30 Mar 2009

Onchocerciasis parasite shows signs of resistance

Onchocerciasis is an infection caused by Onchocerca volvulus, a parasite nematode worm transmitted to humans by a species of black fly of the Simulium genus whose larvae develop in fast-flowing rivers.

31 Jan 2008

Study paves way for mass co-delivery of three antiparasitic drugs

Findings from a new study in Zanzibar, published January 23 in PLoS Neglected Tropical Diseases, pave the way for the World Health Organization (WHO) to recommend the mass co-delivery of three anti-parasitic drugs for the first time.

24 Jan 2008

Mass drug treatment for elephantiasis is affordable compared with other public health programs

Once-yearly administration of two anti-parasitic drugs to control lymphatic filariasis (elephantiasis) costs just $0.06 to $2.23 per person treated, making it comparatively inexpensive, according to a major new international study of treatment costs.

31 Oct 2007

Ivermectin is causing genetic selection in river blindness parasite

Ivermectin, the standard drug for treating river blindness (onchocerciasis), is causing genetic changes in the parasite that causes the disease, according to a new study by Roger Prichard (McGill University, Canada) and colleagues, published on August 30, 2007 in the open-access journal PLoS Neglected Tropical Diseases.

30 Aug 2007

WHO-based tropical disease research programme to focus on emerging diseases

The World Health Organization (WHO) based Special Programme for Research and Training in Tropical Diseases (TDR) has adopted a new strategy for strengthening and expanding research to prevent and control 'infectious diseases of poverty.'

22 Jun 2007

Drug resistance of parasite which causes river blindness could lead to breakouts of the disease

Development of drug resistance in the parasite which causes river blindness could lead to breakouts of the disease in communities where it has been brought under control, conclude authors of an article in The Lancet.

17 Jun 2007

Colitis symptoms 27 years later

The unusual case of a woman whose symptoms of colitis emerged 27 years after she left the country in which she was infected is detailed in a Case Report in the Lancet.

17 Jun 2007

Onchocerciasis treatment reduces prevalence and intensity by 38%

Onchocerciasis, river blindness or craw craw is an endemic disease in Bioko Island, Equatorial Guinea.

1 Aug 2006

Egyptian program to eliminate elephantiasis successful

Organizers of a 20-year global effort to eliminate a parasitic infection that is a leading cause of disability have an early victory to savor: a five-year Egyptian elimination campaign has mostly succeeded, according to a new report in the March 25 issue of The Lancet.

28 Mar 2006

Tropical diseases such as sleeping sickness, schistosomiasis, river blindness, hookworm, elephantiasis, and blinding trachoma are being ignored

"The big three" infections AIDS, TB and malaria have caught the world's attention but other disabling and fatal infectious diseases in Africa are being ignored, say three eminent tropical disease researchers in the international health journal PLoS Medicine.

11 Oct 2005

First new treatment for Elephantiasis (lymphatic filariasis)

Scientists at the Liverpool School of Tropical Medicine have proved that a single course of one antibiotic may hold the key to curing the parasitic worm disease Elephantiasis (lymphatic filariasis) that has been one of the most common causes of global disability since Biblical times.

21 Jun 2005

Single course of one antibiotic can successfully treat elephantiasis

A single course of one antibiotic can successfully treat elephantiasis (filariasis) - a parasitic worm disease that is one of the most common causes of global disability, concludes a study published in this week’s issue of The Lancet.

16 Jun 2005